Pyxis Oncology, Inc. (PYXS) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts PYXS Hot Sheet
Join SI Premium – FREE
Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q2 EPS of ($0.29), $0.05 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZZ, Inc. (AZZ) Tops Q2 EPS by 15c; raises guidance
- Rio Tinto Q3 copper output rises 27%, iron ore sales up 3%
- Equus Total Return gets NYSE non-compliance notice over share price
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
